MimiVax LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:MimiVax LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10979
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
MimiVax LLC (MimiVax) is a pharmaceutical company that discovers and develops immunotherapeutic vaccines and targeted therapies for the treatment of cancer. The company’s lead candidate is SurVaxM. Its SurVaxM is a cancer vaccine that stimulates a potent immune response and the survivin molecule and an important cellular protein which sustains the viability of tumor cells and can be delivered through simple injection. MimiVax’s SurVaxM is under clinical trials in recurrent glioma and newly diagnosed glioblastoma; prolongs survival in pre-clinical models of ovarian, brain, renal and prostate cancers; survivin is a cell-survival protein that is present in most cancer and rarely detectable in normal tissue and immunotherapeutic vaccine demonstrate safety and tolerability in a phase. The company is a spin-off from Roswell Park Cancer Institute. MimiVax is headquartered in Buffalo, New York, the US.

MimiVax LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
MimiVax LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MimiVax LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MimiVax LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MimiVax LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
MimiVax LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MimiVax LLC, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
MimiVax Raises USD1.55 Million in Venture Financing 10
MimiVax Raises Funds through Seed Financing 11
Licensing Agreements 12
MimiVax Enters into Licensing Agreement with Roswell Park Cancer Institute 12
MimiVax LLC – Key Competitors 13
MimiVax LLC – Key Employees 14
MimiVax LLC – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
08/07/2017: FDA Awards Orphan Status to Brain Cancer Vaccine Developed at Roswell Park Cancer Institute 16
03/26/2018: Roswell Park Research on Survivin Opens Up New Avenues for Cancer Immunotherapy 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
MimiVax LLC, Pharmaceuticals & Healthcare, Key Facts 2
MimiVax LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MimiVax LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
MimiVax LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MimiVax LLC, Deals By Therapy Area, 2012 to YTD 2018 8
MimiVax LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
MimiVax Raises USD1.55 Million in Venture Financing 10
MimiVax Raises Funds through Seed Financing 11
MimiVax Enters into Licensing Agreement with Roswell Park Cancer Institute 12
MimiVax LLC, Key Competitors 13
MimiVax LLC, Key Employees 14

List of Figures
MimiVax LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
MimiVax LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
MimiVax LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
MimiVax LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
MimiVax LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
MimiVax LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
MimiVax LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
MimiVax LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[MimiVax LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Red Rock Resorts, Inc. (RRR):企業の財務・戦略的SWOT分析
    Red Rock Resorts, Inc. (RRR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Flynn Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Flynn Pharma Ltd (Flynn Pharma) is a pharmaceutical company that manufactures and markets barbiturate products, and oral and injectable antibiotics. The company’s products include cefuroxime, circadin, distaclor, keflex, medikinet tablets, medikinet XL capsules, nebcin, nizatidine, phenytoin …
  • DIC Corp (4631):企業の財務・戦略的SWOT分析
    DIC Corp (4631) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Citigroup Inc:企業のM&A・事業提携・投資動向
    Citigroup Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Citigroup Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • U.S. Geothermal Inc. (HTM):企業の財務・戦略的SWOT分析
    U.S. Geothermal Inc. (HTM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Orient Corporation:企業の戦略・SWOT・財務情報
    Orient Corporation - Strategy, SWOT and Corporate Finance Report Summary Orient Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Dalian Wanda Group:企業の戦略・SWOT・財務情報
    Dalian Wanda Group - Strategy, SWOT and Corporate Finance Report Summary Dalian Wanda Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Swiss Re Group:企業のM&A・事業提携・投資動向
    Swiss Re Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Swiss Re Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Galliford Try Holdings Plc (GFRD):企業の財務・戦略的SWOT分析
    Galliford Try Holdings Plc (GFRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • A2B Australia Limited:企業の戦略・SWOT・財務分析
    A2B Australia Limited - Strategy, SWOT and Corporate Finance Report Summary A2B Australia Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • DAMAC Real Estate Development Ltd:企業の戦略・SWOT・財務情報
    DAMAC Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report Summary DAMAC Real Estate Development Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Evogene Ltd (EVGN):企業の財務・戦略的SWOT分析
    Summary Evogene Ltd (Evogene), a subsidiary of Compugen Ltd, is a biotechnology company that offers plant genomic services. The company offers solutions for crop production improvement through breeding. It develops biotechnology and advanced breeding improved traits for crops that feed the world, in …
  • Allied Cooperative Insurance Group:企業の戦略・SWOT・財務情報
    Allied Cooperative Insurance Group - Strategy, SWOT and Corporate Finance Report Summary Allied Cooperative Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Virbac Corporation
    Virbac Corporation - Strategy, SWOT and Corporate Finance Report Summary Virbac Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • WEC Energy Group Inc (WEC):電力:M&Aディール及び事業提携情報
    Summary WEC Energy Group, Inc. (WEC) is a diversified holding company that carries out the generation and distribution of electricity in southeastern Wisconsin, east central Wisconsin, northern Wisconsin, and Michigan's Upper Peninsula; and transports and distributes natural gas in the upper peninsu …
  • Delta Electricity:企業の発電所・SWOT分析2018
    Delta Electricity - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Franklin Resources, Inc.:企業の戦略・SWOT・財務情報
    Franklin Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Franklin Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Reliance Power Ltd (RPOWER):電力:M&Aディール及び事業提携情報
    Summary Reliance Power Ltd (RPower), formerly Reliance Energy Generation Private Limited, is a power generation and coal resources company. It develops, constructs, and operates power projects and coal mines. The company produces electricity from various sources of electricity including coal, solar …
  • ExlService Holdings, Inc.:企業の戦略・SWOT・財務情報
    ExlService Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary ExlService Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • ScanSource Inc (SCSC):企業の財務・戦略的SWOT分析
    ScanSource Inc (SCSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆